Back
Apellis Pharmaceuticals Stock Price Chart
Groundbreaking AI Developed In Small Georgia Town Destroys Wall Street
See the remarkable discovery.
Sell
34
APLS
Apellis Pharmaceuticals
Last Price:
39.81
Seasonality Move:
-5.11%
7 Day Trial
ALL ACCESS PASS
$
7
$1,300 into $45,000 in just 4 MONTHS?!
See here to see the full details.- The current trend is relatively stagnant and APLS is experiencing slight buying pressure.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.35 | Buy |
| 20-day SMA: | 38 | Buy |
| 50-day SMA: | 39.79 | Sell |
| 200-day SMA: | 52.12 | Sell |
| 8-day EMA: | 38.1 | Buy |
| 20-day EMA: | 38.47 | Buy |
| 50-day EMA: | 40.79 | Sell |
| 200-day EMA: | 49.63 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.6 | Sell |
| Relative Strength Index (14 RSI): | 50.1 | Buy |
| Chaikin Money Flow: | 536240 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.59 - 39.97) | Buy |
| Bollinger Bands (100): | (38.43 - 54.53) | Sell |
Apellis Pharmaceuticals Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
- Apellis Pharmaceuticals share price is 38.88 while APLS 8-day simple moving average is 38.35, which is a Buy signal.
- The stock price of APLS is 38.88 while Apellis Pharmaceuticals 20-day SMA is 38.00, which makes it a Buy.
- Apellis Pharmaceuticals 50-day simple moving average is 39.79 while APLS share price is 38.88, making it a Sell technically.
- APLS stock price is 38.88 and Apellis Pharmaceuticals 200-day simple moving average is 52.12, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a Sell
The current Apellis Pharmaceuticals [APLS] share price is $38.88. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
4.72B
Price in USD:
38.88
Share Volume:
1.69M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
73.80
52-Week Low:
19.83
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?
The Apellis Pharmaceuticals stock price is 38.88 USD today. -
Will APLS stock go up or go down?
Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Apellis Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
- Apellis Pharmaceuticals share price is 38.88 while APLS 8-day exponential moving average is 38.10, which is a Buy signal.
- The stock price of APLS is 38.88 while Apellis Pharmaceuticals 20-day EMA is 38.47, which makes it a Buy.
- Apellis Pharmaceuticals 50-day exponential moving average is 40.79 while APLS share price is 38.88, making it a Sell technically.
- APLS stock price is 38.88 and Apellis Pharmaceuticals 200-day simple moving average is 49.63, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.88 per share, an increase next quarter of $0.27 per share, an increase this year of $3.51 per share, and an increase next year of $1.98 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
- APLS Moving Average Covergence Divergence (MACD) indicator is -0.6, suggesting Apellis Pharmaceuticals is a Sell
- Apellis Pharmaceuticals Relative Strength Index (RSI) is 50.1, which suggest Apellis Pharmaceuticals is overbought
- The Bollinger Bands (25) for Apellis Pharmaceuticals is (36.59 - 39.97), which suggest Apellis Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Apellis Pharmaceuticals is (38.43 - 54.53), which suggest Apellis Pharmaceuticals is a Sell
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.